SCHEMBL6826387

SCHEMBL6826387

OC[C@H](O)COc1ccc(Nc2ncc(Br)c(Nc3ccc(F)cc3)n2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 8/20 0.64
CDK4 P11802 7/20 0.64
CDK1 P06493 5/20 0.50
CHEK1 O14757 2/20 0.49
NTRK2 Q16620 2/20 0.49
AURKA O14965 3/20 0.48
IGF1R P08069 3/20 0.48
SYK P43405 6/20 0.47
GSK3B P49841 2/20 0.46
KDR P35968 4/20 0.44
CA2 P00918 3/20 0.44
CDK7 P50613 2/20 0.44
CDK9 P50750 2/20 0.44
CCNT1 O60563 1/20 0.44
CCND1 P24385 1/20 0.44
CCNH P51946 1/20 0.44
CCNB1 P14635 2/20 0.44
CCNE1 P24864 2/20 0.44
CDC7 O00311 1/20 0.43
PLK4 O00444 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6829108 1.00 CDK2 (0.64) CDK2CDK4CDK1CHEK1NTRK2
SCHEMBL6829794 1.00 CDK2 (0.64) CDK2CDK4CDK1CHEK1NTRK2
SCHEMBL6829247 0.91 CDK4 (0.59) CDK2CDK4CDK1CHEK1NTRK2
SCHEMBL6829254 0.91 CDK4 (0.59) CDK2CDK4CDK1CHEK1NTRK2
SCHEMBL6644486 0.79 CDK4 (0.86) CDK2CDK4CHEK1NTRK2IGF1R
SCHEMBL656614 0.79 SYK (0.75) CDK2CDK4AURKASYKBTK
SCHEMBL29644986 0.78 CDK4 (1.00) CDK2CDK4IGF1RGSK3B
SCHEMBL6644101 0.78 CDK2 (0.75) CDK2CDK4CDK1CHEK1NTRK2
SCHEMBL29644990 0.78 CDK4 (1.00) CDK2CDK4IGF1RGSK3B
SCHEMBL5581900 0.78 CDK4 (1.00) CDK2CDK4IGF1RGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004046118-A2 2-4-(DI-PHENYL-AMINO)-PYRIMIDINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2004-06-03 WO disclosed